PerpEquities

Laporan laba rugi Caris Life Sciences, Inc. (CAI)

NASDAQ · Healthcare · Biotechnology · Karyawan: 1.846 · CEO: David Dean Halbert

Harga
$34,33 -5,01%
Kapitalisasi pasar
$9,7 M
Nilai perusahaan
$9,47 M
Laporan terakhir
Q2 '26 diajukan 2026-08-05
Laporan berikutnya
2026-11-04 Estimasi EPS: $0,03

Caris Life Sciences, Inc. (CAI) untuk Q2 '26: pendapatan $264 jt (+45,4% yoy), laba operasional $26,9 jt (10,2% dari pendapatan), laba bersih -$637 rb. Dalam empat kuartal terakhir pendapatan mencapai $990 jt.

Laporan laba rugi

Laporan laba rugiTrenQ2 '21Q3 '21Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Pendapatan$85,7 jt$101 jt$80,7 jt$100 jt$102 jt$130 jt$121 jt$181 jt$217 jt$293 jt$216 jt$264 jt
Beban pokok pendapatan$0$46,7 jt$54,6 jt$62,5 jt$57,2 jt$59,2 jt$63,9 jt$67,7 jt$69,3 jt$72 jt$74,8 jt$84,1 jt
Laba kotor$85,7 jt$54,1 jt$26,1 jt$37,6 jt$44,4 jt$70,7 jt$57,1 jt$114 jt$148 jt$221 jt$141 jt$180 jt
Riset & pengembangan$0$0$34,4 jt$24,8 jt$27,6 jt$27,1 jt$23,1 jt$25 jt$21,6 jt$31,8 jt$5,37 jt$32,4 jt
Penjualan & pemasaran$0$0$38,5 jt$38,7 jt$36,8 jt$0$38,6 jt$42,3 jt$41,3 jt$44,2 jt$45 jt$53,8 jt
Umum & administrasi$10,2 jt$12,3 jt$45,5 jt$41,1 jt$40,9 jt$0$53,4 jt$64,4 jt$52 jt$56,5 jt$59,7 jt$66,5 jt
Beban operasional lainnya$24,7 jt$0$0-$134 jt$0$0$1 rb-$36 jt$0$0$25,9 jt$0
Beban operasional$34,9 jt$12,3 jt$118 jt-$29,5 jt$105 jt$108 jt$115 jt$95,7 jt$115 jt$133 jt$136 jt$153 jt
Laba operasional$50,8 jt$66,4 jt-$92,2 jt$67 jt-$60,8 jt-$37 jt-$58 jt$18 jt$32,6 jt$88,4 jt$5,28 jt$26,9 jt
Pendapatan bunga$0$0$1,77 jt$2,64 jt$1,74 jt$970 rb$503 rb$1,62 jt$7,36 jt$7,02 jt$6,83 jt$6,82 jt
Beban bunga$11,1 jt$0$9,29 jt$13,7 jt$13,8 jt$13,3 jt$12,8 jt$19,2 jt$13,5 jt$11,4 jt$12,8 jt$9,23 jt
Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...)-$74 rb$0$9,51 jt$120 jt$0$0$31,8 jt$70,6 jt-$5,19 jt-$4,9 jt-$6,88 jt$18,3 jt
Total pendapatan non-operasional-$11 jt-$11,6 jt-$18,8 jt-$133 jt-$6,89 jt$99 rb-$44,6 jt-$89,8 jt-$8,32 jt-$6,45 jt-$5,93 jt-$27,5 jt
Laba sebelum pajak$39,8 jt$54,8 jt-$111 jt-$66,2 jt-$67,7 jt-$36,9 jt-$103 jt-$71,8 jt$24,3 jt$82 jt-$644 rb-$614 rb
Pajak penghasilan$1,86 jt$3,68 jt$0$0$0$0$0$0$0$0-$134 rb$23 rb
Laba bersih$37,9 jt$51,2 jt-$111 jt-$66,2 jt-$67,7 jt-$36,9 jt-$103 jt-$71,8 jt$24,3 jt$82 jt-$510 rb-$637 rb
EPS (dasar)$2,07$2,95-$0,53-$0,35-$0,33-$0,22-$0,40-$1,93$0,09$0,29-$0,00-$0,00
EPS (dilusian)$2,04$2,92-$0,53-$0,35-$0,33-$0,22-$0,40-$1,87$0,08$0,28-$0,00-$0,00
Saham (dasar, rata-rata tertimbang)17,3 jt17,3 jt255 jt255 jt281 jt281 jt255 jt268 jt282 jt282 jt283 jt283 jt
Saham (dilusian, rata-rata tertimbang)17,5 jt17,5 jt255 jt255 jt281 jt281 jt255 jt276 jt297 jt290 jt283 jt283 jt
Depresiasi & amortisasi$0$32,9 jt$17,7 jt$11,6 jt$10,5 jt$9,07 jt$7,05 jt$6,41 jt$4,87 jt$4,29 jt$5,07 jt$6,54 jt
EBITDA$50,9 jt$87,7 jt-$84 jt-$40,9 jt-$50,3 jt-$28 jt-$82,8 jt-$46,2 jt$42,7 jt$97,6 jt$17,2 jt$15,2 jt

Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.

Pendapatan, laba operasional, dan pertumbuhan

kuartalan

Margin

kuartalan

Biaya sebagai % pendapatan

kuartalan

Laporan lainnya

Sumber

Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30

Data per 2026-11-02